Pharmalittle: Biogen argues investors overreacted; AstraZeneca wins a key immunotherapy approval – STAT
STAT |
Pharmalittle: Biogen argues investors overreacted; AstraZeneca wins a key immunotherapy approval
STAT ood morning, everyone, and welcome to another working week. Those of you on our side of the pond had, of course, an extended respite thanks to a federal holiday, and we hope your time was relaxing and invigorating, because that oh-so-familiar routine … US FDA Approves AstraZeneca's Immunotherapy for Lung Cancer AstraZeneca PLC (NYSE:AZN) won crucial approval from US regulators for use in lung cancer |
